AlphaGrep UK
BMY icon

AlphaGrep UK’s Bristol-Myers Squibb BMY Stock Holding History

AlphaGrep UK’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$227K Sell
3,644
-3,962
-52% -$250K 0.07% 632
2026
Q2 		$438K Buy
+7,606
New +$437K 0.13% 279
2026
Q1 		– Sell
-13,205
Closed -$712K – 790
2025
Q4 		$712K Buy
+13,205
New +$635K 0.24% 99

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

AlphaGrep UK's BMY Position: Q3 2026 in Review

AlphaGrep UK reduced its Bristol-Myers Squibb (BMY) stake by 52% in Q3 2026, selling an estimated $250K and leaving 3,644 shares worth $227K. The position accounts for 0.07% of the portfolio, ranked #632.

AlphaGrep UK first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $712K in Q4 2025. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • AlphaGrep UK held 3,644 shares of Bristol-Myers Squibb worth $227K as of Q3 2026.
  • AlphaGrep UK sold 3,962 Bristol-Myers Squibb shares in Q3 2026, an estimated $250K.
  • Bristol-Myers Squibb made up 0.07% of AlphaGrep UK's portfolio in Q3 2026, its #632 holding.
  • AlphaGrep UK first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Bristol-Myers Squibb position peaked at $712K in Q4 2025.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.